Skip to main content
Type at least 3 characters

34,385 articles

Original Research

Published on 12 Oct 2023

The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank

in Cancer Immunity and Immunotherapy

  • James M. Lonie
  • Sandra Brosda
  • Vanessa F. Bonazzi
  • Lauren G. Aoude
  • Kalpana Patel
  • Ian Brown
  • Sowmya Sharma
  • Guy Lampe
  • Venkateswar Addala
  • Lambros T. Koufariotis
Frontiers in Immunology
doi 10.3389/fimmu.2023.1220129
  • 3,009 views
  • 6 citations